AKTX
Akari Therapeutics
AKTX
AKTX
14 hedge funds and large institutions have $14.5M invested in Akari Therapeutics in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.12M | |
| 2 | +$593K | |
| 3 | +$561K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$127K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$71.2K |
Top Sellers
| 1 | -$3.28M | |
| 2 | -$1.05M | |
| 3 | -$759K | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$516K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$214K |